200 related articles for article (PubMed ID: 12052253)
1. CCAAT/enhancer binding proteins in normal mammary development and breast cancer.
Zahnow CA
Breast Cancer Res; 2002; 4(3):113-21. PubMed ID: 12052253
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
3. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
Bundy LM; Sealy L
Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
[TBL] [Abstract][Full Text] [Related]
5. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
[TBL] [Abstract][Full Text] [Related]
6. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP).
Parkin SE; Baer M; Copeland TD; Schwartz RC; Johnson PF
J Biol Chem; 2002 Jun; 277(26):23563-72. PubMed ID: 11980905
[TBL] [Abstract][Full Text] [Related]
8. The role of C/EBPbeta in mammary gland development and breast cancer.
Grimm SL; Rosen JM
J Mammary Gland Biol Neoplasia; 2003 Apr; 8(2):191-204. PubMed ID: 14635794
[TBL] [Abstract][Full Text] [Related]
9. C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development.
Seagroves TN; Lydon JP; Hovey RC; Vonderhaar BK; Rosen JM
Mol Endocrinol; 2000 Mar; 14(3):359-68. PubMed ID: 10707954
[TBL] [Abstract][Full Text] [Related]
10. C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavage.
Welm AL; Timchenko NA; Darlington GJ
Mol Cell Biol; 1999 Mar; 19(3):1695-704. PubMed ID: 10022857
[TBL] [Abstract][Full Text] [Related]
11. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells.
Eaton EM; Hanlon M; Bundy L; Sealy L
J Cell Physiol; 2001 Oct; 189(1):91-105. PubMed ID: 11573208
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein).
Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
Mol Pharmacol; 2005 Jun; 67(6):2088-101. PubMed ID: 15778453
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.
Zahnow CA
Expert Rev Mol Med; 2009 Apr; 11():e12. PubMed ID: 19351437
[TBL] [Abstract][Full Text] [Related]
14. Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins.
Okuma T; Hirata M; Yano F; Mori D; Kawaguchi H; Chung UI; Tanaka S; Saito T
Biomed Res; 2015; 36(1):21-9. PubMed ID: 25749148
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.
Zahnow CA; Younes P; Laucirica R; Rosen JM
J Natl Cancer Inst; 1997 Dec; 89(24):1887-91. PubMed ID: 9414177
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix regulates alpha s1-casein gene expression in rabbit primary mammary cells and CCAAT enhancer binding protein (C/EBP) binding activity.
Jolivet G; Meusnier C; Chaumaz G; Houdebine LM
J Cell Biochem; 2001; 82(3):371-86. PubMed ID: 11500914
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer binding protein alpha (C/EBPalpha) is an important mediator of mouse C/EBPbeta protein isoform production.
Burgess-Beusse BL; Timchenko NA; Darlington GJ
Hepatology; 1999 Feb; 29(2):597-601. PubMed ID: 9918941
[TBL] [Abstract][Full Text] [Related]
19. Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells.
Talukder AH; Wang RA; Kumar R
Oncogene; 2002 Jun; 21(27):4289-300. PubMed ID: 12082616
[TBL] [Abstract][Full Text] [Related]
20. Nulliparous CCAAT/enhancer binding proteindelta (C/EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia.
Gigliotti AP; Johnson PF; Sterneck E; DeWille JW
Exp Biol Med (Maywood); 2003 Mar; 228(3):278-85. PubMed ID: 12626772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
